文献速递乳房整形与再造美容整形

自体脂肪移植治疗乳房切除术后疼痛综合征:一项随机对照试验

Autologous Fat Grafting as Treatment of Postmastectomy Pain Syndrome: A Randomized Controlled Trial.
PubMed 文献 · Plast Reconstr Surg · 2022-01-01

该单中心、双盲、随机对照试验于2017年10月至2020年9月开展,比较脂肪移植与安慰剂(生理盐水)对乳房切除术后疼痛综合征的疗效。35例完成6个月随访(干预组18例,对照组17例),两组在平均疼痛、最大疼痛及神经病理性疼痛方面均无统计学显著变化;对照组情绪问题参数有统计学显著改善而干预组恶化,未观察到严重不良事件。作者未发现脂肪移植优于安慰剂的证据。

要点

  • 脂肪移植组与安慰剂组在平均疼痛、最大疼痛和神经病理性疼痛上均无统计学显著变化。
  • 对照组情绪问题参数有统计学显著改善,干预组则恶化。
  • 未观察到严重不良事件。

核心结论

  • 作者未发现证据支持脂肪移植在治疗乳房切除术后疼痛综合征方面优于安慰剂。

研究设计与样本

  • 单中心、双盲、随机对照试验,两臂,于2017年10月至2020年9月开展。
  • 干预组接受瘢痕松解术(rigottomy)加脂肪移植至疼痛区域,对照组接受瘢痕松解术加生理盐水安慰剂。
  • 35例完成随访:干预组18例,对照组17例;随访6个月。

主要发现

  • 平均疼痛、最大疼痛及神经病理性疼痛均未检测到统计学显著变化。
  • 生活质量方面,对照组报告情绪问题参数有统计学显著改善,而干预组报告恶化。
  • 未观察到严重不良事件。

关键数值与推荐

  • 主要结局为采用数字评分量表(Numerical Rating Scale)测量的疼痛程度。
  • 次要结局为神经病理性疼痛的程度与性质(神经病理性疼痛症状量表,Neuropathic Pain Symptom Inventory)及生活质量(36项简短健康调查,36-Item Short-Form Health Survey)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postmastectomy pain syndrome is a common and disabling side effect of breast cancer treatment. Medical treatment seems to be insufficient for a considerable proportion of patients. Fat grafting has shown promise in relieving pain from postmastectomy pain syndrome, but no randomized clinical trial comparing fat grafting to a sham operation has been performed to date. The authors' objective was to compare the effect of fat grafting compared to a sham operation for treating postmastectomy pain syndrome. METHODS: The authors conducted a single-center, double-blind, randomized clinical trial with two arms between October of 2017 and September of 2020. The authors assessed four patients suffering from postmastectomy pain syndrome for inclusion. The intervention group received scar-releasing rigottomy and fat grafting to the area of pain. The control group received scar-releasing rigottomy and a placebo of saline solution. The primary outcome was the degree of pain measured using the Numerical Rating Scale. The secondary outcomes were the degree and quality of neuropathic pain (Neuropathic Pain Symptom Inventory) and quality of life (36-Item Short-Form Health Survey). Follow-up was 6 months. RESULTS: Thirty-five participants completed follow-up: 18 participants in the intervention group and 17 in the control group. The authors detected no statistically significant changes in average and maximum pain or neuropathic pain. Regarding quality of life, the control group reported a statistically significant improvement in emotional problem parameters, whereas the intervention group reported a deterioration. The authors observed no serious adverse effects. CONCLUSION: The authors did not find evidence to support that fat grafting is superior to a placebo when treating postmastectomy pain syndrome. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, I.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Sollie M, Toyserkani NM, Bille C, et al. Autologous Fat Grafting as Treatment of Postmastectomy Pain Syndrome: A Randomized Controlled Trial. Plast Reconstr Surg. 2022. PMID: 35077402. doi:10.1097/PRS.0000000000008705

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。